vs
爱尔康（ALC）与Dover Corporation（DOV）财务数据对比。点击上方公司名可切换其他公司
爱尔康的季度营收约是Dover Corporation的1.2倍（$2.6B vs $2.1B），Dover Corporation净利率更高（13.4% vs 6.8%，领先6.7%），Dover Corporation同比增速更快（12.5% vs 4.0%）
爱尔康是瑞美合资的制药及医疗器械企业，专注于眼健康护理产品领域。公司注册地为瑞士弗里堡州，全球总部设于日内瓦，核心运营基地位于美国得克萨斯州沃思堡，当地员工规模约4500人。
美国工业产品综合性制造集团，1955年成立，总部位于伊利诺伊州唐纳斯格罗夫。旗下业务分为工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术五大板块，为标普500指数成分股，纽交所交易代码DOV，2024年位列财富榜单第448位。
ALC vs DOV — 直观对比
营收规模更大
ALC
是对方的1.2倍
$2.1B
营收增速更快
DOV
高出8.5%
4.0%
净利率更高
DOV
高出6.7%
6.8%
损益表 — Q2 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.6B | $2.1B |
| 净利润 | $176.0M | $282.1M |
| 毛利率 | 53.5% | 39.1% |
| 营业利润率 | 9.5% | 16.5% |
| 净利率 | 6.8% | 13.4% |
| 营收同比 | 4.0% | 12.5% |
| 净利润同比 | -21.1% | 22.2% |
| 每股收益（稀释后） | $0.35 | $2.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALCDOV
| Q1 26 | — | $2.1B | ||
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | $2.6B | $2.0B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $2.5B | $2.2B |
净利润ALCDOV
| Q1 26 | — | $282.1M | ||
| Q4 25 | — | $282.1M | ||
| Q3 25 | — | $302.0M | ||
| Q2 25 | $176.0M | $279.1M | ||
| Q1 25 | — | $230.8M | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $347.1M | ||
| Q2 24 | $223.0M | $281.8M |
毛利率ALCDOV
| Q1 26 | — | 39.1% | ||
| Q4 25 | — | 39.1% | ||
| Q3 25 | — | 40.1% | ||
| Q2 25 | 53.5% | 39.9% | ||
| Q1 25 | — | 40.0% | ||
| Q4 24 | — | 41.4% | ||
| Q3 24 | — | 38.5% | ||
| Q2 24 | 55.0% | 37.7% |
营业利润率ALCDOV
| Q1 26 | — | 16.5% | ||
| Q4 25 | — | 16.5% | ||
| Q3 25 | — | 18.2% | ||
| Q2 25 | 9.5% | 17.3% | ||
| Q1 25 | — | 15.9% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | 12.7% | 17.0% |
净利率ALCDOV
| Q1 26 | — | 13.4% | ||
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | 6.8% | 13.6% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 96.4% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | 8.9% | 12.9% |
每股收益（稀释后）ALCDOV
| Q1 26 | — | $2.06 | ||
| Q4 25 | — | $2.06 | ||
| Q3 25 | — | $2.19 | ||
| Q2 25 | $0.35 | $2.02 | ||
| Q1 25 | — | $1.67 | ||
| Q4 24 | — | $10.38 | ||
| Q3 24 | — | $2.51 | ||
| Q2 24 | $0.45 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | — |
| 总债务越低越好 | — | $3.3B |
| 股东权益账面价值 | $22.1B | $7.4B |
| 总资产 | $31.4B | $13.4B |
| 负债/权益比越低杠杆越低 | — | 0.45× |
8季度趋势，按日历期对齐
现金及短期投资ALCDOV
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $1.4B | — |
总债务ALCDOV
| Q1 26 | — | $3.3B | ||
| Q4 25 | — | $3.3B | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | — | $3.1B | ||
| Q1 25 | — | $3.0B | ||
| Q4 24 | — | $2.9B | ||
| Q3 24 | — | $3.0B | ||
| Q2 24 | — | $3.0B |
股东权益ALCDOV
| Q1 26 | — | $7.4B | ||
| Q4 25 | — | $7.4B | ||
| Q3 25 | — | $7.7B | ||
| Q2 25 | $22.1B | $7.4B | ||
| Q1 25 | — | $7.1B | ||
| Q4 24 | — | $7.0B | ||
| Q3 24 | — | $5.7B | ||
| Q2 24 | $20.9B | $5.4B |
总资产ALCDOV
| Q1 26 | — | $13.4B | ||
| Q4 25 | — | $13.4B | ||
| Q3 25 | — | $13.4B | ||
| Q2 25 | $31.4B | $13.2B | ||
| Q1 25 | — | $12.6B | ||
| Q4 24 | — | $12.5B | ||
| Q3 24 | — | $11.9B | ||
| Q2 24 | $29.7B | $11.3B |
负债/权益比ALCDOV
| Q1 26 | — | 0.45× | ||
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.40× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 0.42× | ||
| Q4 24 | — | 0.42× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 0.55× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
